Ocumension Therapeutics
Related Filers (2)
Other (5)
144
Thursday, 1/11/2024
Filing for proposed sale of securities under Rule 144
144
Tuesday, 12/5/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 5/26/2023
Filing for proposed sale of securities under Rule 144
144/A
Friday, 5/26/2023
Filing for proposed sale of securities under Rule 144
144/A
Friday, 5/26/2023
Filing for proposed sale of securities under Rule 144
Ownership (6)
4
Tuesday, 1/16/2024
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/7/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 4/30/2021
ALIMERA SCIENCES INC: Major Shareholders
3
Friday, 4/30/2021
ALIMERA SCIENCES INC: Initial statement of beneficial ownership of securities
SC 13D
Friday, 1/22/2021
EyePoint Pharmaceuticals, Inc.: Major Shareholders
3
Thursday, 1/14/2021
EyePoint Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities